Caris Life Sciences, Inc.
General ticker "CAI" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $7.1B (TTM average)
Caris Life Sciences, Inc. follows the US Stock Market performance with the rate: 29.1%.
Estimated limits based on current volatility of 4.0%: low 19.93$, high 21.60$
Factors to consider:
- Total employees count: 1846 as of 2025
- US accounted for 98.7% of revenue in the fiscal year ended 2025-12-31
- Top business risk factors: Market competition, Operational and conduct risks, Reimbursement changes, Regulatory and compliance, Capital access
Short-term CAI quotes
Long-term CAI plot
Financial data
| YTD | 2025-12-31 |
|---|---|
| Operating Revenue | $812.03MM |
| Operating Expenses | $766.92MM |
| Operating Income | $45.11MM |
| Non-Operating Income | $-113.20MM |
| Interest Expense | $56.85MM |
| R&D Expense | $45.31MM |
| Income(Loss) | $-68.09MM |
| Net Income(Loss)* | $-537.96MM |
| Stockholders Equity | $577.31MM |
| Assets | $1,125.66MM |
| Operating Cash Flow | $83.16MM |
| Capital expenditure | $16.26MM |
| Investing Cash Flow | $-16.26MM |
| Financing Cash Flow | $664.99MM |
| Earnings Per Share** | $-3.22 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.